Clinical Trials Directory

Trials / Conditions / Chemotherapy Induced Neuropathic Pain

Chemotherapy Induced Neuropathic Pain

6 registered clinical trials studyying Chemotherapy Induced Neuropathic Pain — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingProspective Exploratory Study of a Multiomic Blood Biomarker Panel to Predict Chemotherapy-Induced Peripheral
NCT07511569
Centre Hospitalier de Bligny—
Enrolling By InvitationHelping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PE
NCT07061769
FluxWear, INCN/A
RecruitingEfficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
NCT06848348
Dogwood Therapeutics Inc.Phase 2
TerminatedA Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodo
NCT05359133
Wex Pharmaceuticals Inc.Phase 2
WithdrawnTrial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients
NCT02989129
M.D. Anderson Cancer CenterEARLY_Phase 1
CompletedPregabalin Treatment Of Peripheral Neuropathic Pain Associated With Diabetic Peripheral NeP (DPN), Postherpeti
NCT00407511
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Phase 4